Worse Clinical Outcomes in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Relevance to Impaired Endothelial Progenitor Cells Mobilization
Open Access
- 30 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e50739
Abstract
Although the clinical outcome of acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM) is well established to be worse than for non-diabetic patients, the reasons for this remain unclear. We hypothesized that this may be related to impairment of bone marrow-derived endothelial progenitor cells (EPCs) mobilization. We observed short term bone marrow EPCs mobilization and long term clinical outcomes in 62 AMI patients with or without T2DM and investigated EPCs levels as well as bone marrow pathway changes in a rat model of diabetes after AMI. Patients with T2DM exhibited a delay (peak time diabetics vs. non-diabetics: day 7 vs. day 5) and a decrease in EPCs mobilization (diabetics vs. non-diabetics: 285±56/106 mononuclear cells (MNCs) vs. 431±88/106 MNCs, p<0.05) within one month after AMI. Plasma levels of VEGF and SDF-1α as well as of hsCRP were higher in T2DM patients. Over a mean of 2.26 years follow-up, T2DM patients exhibited a pronounced decrease in LVEF as well as an increase in clinical events. Glucose (HR 2.01, 95% CI 1.42–2.85, p = 0.008), first day EPC (HR 0.974, 95% CI 0.952–0.997, p = 0.02) and seven day EPCs (HR 0.966, 95% CI 0.945–0.988, p = 0.003) were independent prognostic variables for cardiovascular mortality. In a diabetic rat model of AMI, decreased circulating EPCs was accompanied by lower expression of phospho-Akt, phospho-eNOS, HIF, MMP-9 and MMP-9 activity in the bone marrow as well as impaired cardiac function, angiogenesis and increased left ventricle remodeling. Bone marrow EPCs mobilization is delayed and reduced in diabetes, with impaired HIF/p-Akt/p-eNOS/MMP-9 signaling. This is likely to contribute to the deterioration in cardiac function and worsened clinical outcome seen in patients with T2DM.Keywords
This publication has 40 references indexed in Scilit:
- Diabetes Mellitus Induces Bone Marrow MicroangiopathyArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: Implications for increased cardiovascular riskAtherosclerosis, 2010
- Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetesClinical and Experimental Pharmacology and Physiology, 2009
- Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary interventionHeart, 2009
- Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitusCardiovascular Diabetology, 2009
- From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cellsEuropean Heart Journal, 2008
- Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1αJournal of Clinical Investigation, 2007
- A new rat model of diabetic macrovascular complicationCardiovascular Research, 2007
- Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular EventsCirculation, 2005
- C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and FunctionCirculation, 2004